Australia Considers Adoption of EU Drug Development Guidelines

The Therapeutic Goods Administration is looking to Europe for guidance on drug development, including clinical development of biosimilar drugs, investigations of lipid disorder therapies and evaluations of bacterial infections.
International Pharmaceutical Regulatory Monitor